3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
16
Unknown
5
Terminated
3
Recruiting
3
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Burkitt Lymphoma
11
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Leukemia, Biphenotypic, Acute
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Accelerated Phase
4
Blast Crisis
4
Lymphoma
3
Leukemia
3
Rhabdoid Tumor
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid, Chronic-Phase
2
Graft vs Host Disease
2
Down Syndrome
2
Central Nervous System Neoplasms
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Solid Tumors
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Primary Myelofibrosis
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
regorafenib
3
Specimen Handling
3
Nivolumab
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pembrolizumab
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
cabozantinib
2
Etoposide
2
Docetaxel
2
tocilizumab
1
tazemetostat
1
poly ICLC
1
palbociclib
1
naxitamab
1
mifamurtide
1
humanized 3F8 anti-GD2 monoclonal antibody
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Osteosarcoma
×
Methotrexate
×
Clear all
NCT00470223
2025-06-08
OS2006
UNICANCER
Phase 3
Active not recruiting
318 enrolled